当前位置: 首页 > 期刊 > 《中国医药导报》 > 2019年第24期
编号:1356342
SOX11在胶质母细胞瘤中的表达及其临床病理学意义
http://www.100md.com 2019年10月30日 中国医药导报 2019年第24期
     吴景 李晓洁 何杰

    [摘要] 目的 探讨SOX11在胶质母细胞瘤中的表达及其临床病理学意义。 方法 收集2010年9月~2017年1月安徽省立医院病理科存档的胶质母细胞瘤石蜡包埋样本264例,每例样本选取肿瘤区域及瘤旁正常脑组织制作组织芯片,采用全自动免疫组化方法检测SOX11的表达,并分析SOX11表达与患者临床病理特征的关系。结果 胶质母细胞瘤中SOX11表达的总阳性率和强阳性率显著高于配对的瘤旁正常组织(P 0.05)。 结论 SOX11在胶质母细胞瘤中特异性表达,可作为胶质母细胞瘤病理诊断的标志物,其表达水平可能与肿瘤进展有关。

    [关键词] 胶质母细胞瘤;SOX11;免疫组织化学;临床病理学;诊断标志物

    [中图分类号] R739.41? ? ? ? ? [文献标识码] A? ? ? ? ? [文章编号] 1673-7210(2019)08(c)-0011-04

    [Abstract] Objective To investigate the expression and clinical pathological significance of SOX11 in glioblastoma. Methods A total of 264 cases of paraffin-embedded glioblastoma were collected from the Department of Pathology, Anhui Provincial Hospital from September 2010 to January 2017. Each sample was selected from the tumor area and the normal brain tissue of the tumor to make tissue chips. The expression of SOX11 was detected by immunohistochemistry and the relationship between SOX11 expression and clinicopathological features was analyzed. Results The total positive rate and strongly positive rate of SOX11 expression in glioblastoma was significantly higher than that in matched normal tissues of the tumor (P 0.05). Conclusion SOX11 is specifically expressed in glioblastoma and can be used as a marker for the pathological diagnosis of glioblastoma. The expression level of SOX11 may be related to tumor progression. ......

您现在查看是摘要页,全文长 11476 字符